{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:25:31Z","timestamp":1791905131494,"version":"4.3.4"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"Importance<\/jats:title>Investigating how the risk of serious illness after SARS-CoV-2 infection in children and adolescents has changed as new variants have emerged is essential to inform public health interventions and clinical guidance.<\/jats:p><\/jats:sec>Objective<\/jats:title>To examine risk factors associated with hospitalization for COVID-19 or pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) among children and adolescents during the first 2 years of the COVID-19 pandemic and change in risk factors over time.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This population-level analysis of hospitalizations after SARS-CoV-2 infection in England among children and adolescents aged 0 to 17 years was conducted from February 1, 2020, to January 31, 2022. National data on hospital activity were linked with data on SARS-CoV-2 testing, SARS-CoV-2 vaccination, pediatric intensive care unit (PICU) admissions, and mortality. Children and adolescents hospitalized with COVID-19 or PIMS-TS during this time were included. Maternal, elective, and injury-related hospitalizations were excluded.<\/jats:p><\/jats:sec>Exposures<\/jats:title>Previous medical comorbidities, sociodemographic factors, and timing of hospitalization when different SARS-CoV-2 variants (ie, wild type, Alpha, Delta, and Omicron) were dominant in England.<\/jats:p><\/jats:sec>Main Outcomes<\/jats:title>PICU admission and death within 28 days of hospitalization with COVID-19 or PIMS-TS.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 10\u202f540 hospitalizations due to COVID-19 and 997 due to PIMS-TS were identified within 1\u202f125\u202f010 emergency hospitalizations for other causes. The number of hospitalizations due to COVID-19 and PIMS-TS per new SARS-CoV-2 infections in England declined during the second year of the COVID-19 pandemic. Among 10\u202f540 hospitalized children and adolescents, 448 (4.3%) required PICU admission due to COVID-19, declining from 162 of 1635 (9.9%) with wild type, 98 of 1616 (6.1%) with Alpha, and 129 of 3789 (3.4%) with Delta to 59 of 3500 (1.7%) with Omicron. Forty-eight children and adolescents died within 28 days of hospitalization due to COVID-19, and no children died of PIMS-TS (PIMS-S data were limited to November 2020 onward). Risk of severe COVID-19 in children and adolescents was associated with medical comorbidities and neurodisability regardless of SARS-CoV-2 variant. Results were similar when children and adolescents with prior SARS-CoV-2 exposure or vaccination were excluded.<\/jats:p><\/jats:sec>Conclusions<\/jats:title>In this study of data across the first 2 years of the COVID-19 pandemic, risk of severe disease from SARS-CoV-2 infection in children and adolescents in England remained low. Children and adolescents with multiple medical problems, particularly neurodisability, were at increased risk and should be central to public health measures as further variants emerge.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamapediatrics.2023.2357","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T15:33:06Z","timestamp":1690817586000},"page":"947","source":"Crossref","is-referenced-by-count":37,"title":["Pediatric Hospitalizations and ICU Admissions Due to COVID-19 and Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 in England"],"prefix":"10.1001","volume":"177","author":[{"given":"Joseph L.","family":"Ward","sequence":"first","affiliation":[{"name":"University College London Great Ormond St. Institute of Child Health, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Harwood","sequence":"additional","affiliation":[{"name":"Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom"},{"name":"Alder Hey Children\u2019s National Health Service Trust, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Kenny","sequence":"additional","affiliation":[{"name":"Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom"},{"name":"National Health Service England and Improvement, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Cruz","sequence":"additional","affiliation":[{"name":"University College London Great Ormond St. Institute of Child Health, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Clark","sequence":"additional","affiliation":[{"name":"National Health Service England and Improvement, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Davis","sequence":"additional","affiliation":[{"name":"Paediatric Intensive Care Unit, Bristol Royal Hospital for Children, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth S.","family":"Draper","sequence":"additional","affiliation":[{"name":"Paediatric Intensive Care Audit Network, Department of Health Sciences, University of Leicester, Leicester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dougal","family":"Hargreaves","sequence":"additional","affiliation":[{"name":"Mohn Centre for Children\u2019s Health and Wellbeing, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamez N.","family":"Ladhani","sequence":"additional","affiliation":[{"name":"UK Health Security Agency, London, United Kingdom"},{"name":"Immunisation Department, UK Health Security Agency, London, United Kingdom"},{"name":"Centre for Neonatal and Paediatric Infection, St George\u2019s, University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Gent","sequence":"additional","affiliation":[{"name":"Ministry of Health & Wellness, George Town, Cayman Islands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah E.","family":"Williams","sequence":"additional","affiliation":[{"name":"UK Health Security Agency, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Luyt","sequence":"additional","affiliation":[{"name":"Bristol Medical School, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Turner","sequence":"additional","affiliation":[{"name":"National Health Service Grampian, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Whittaker","sequence":"additional","affiliation":[{"name":"Paediatric Infectious Diseases, Imperial College Healthcare National Health Service Trust, London, United Kingdom"},{"name":"Section of Paediatric Infectious Diseases, Faculty of Medicine, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Bottle","sequence":"additional","affiliation":[{"name":"Department of Primary Care and Public Health, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna K.","family":"Fraser","sequence":"additional","affiliation":[{"name":"Cicely Saunders Institute, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell M.","family":"Viner","sequence":"additional","affiliation":[{"name":"University College London Great Ormond St. Institute of Child Health, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"poi230041r1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41591-021-01578-1","article-title":"Deaths in Children and Young People in England following SARS-CoV-2 infection during the first pandemic year: a national study using linked mandatory child death reporting data.","volume":"28","author":"Smith","year":"2022","journal-title":"Nat Med"},{"key":"poi230041r2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101287","article-title":"Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: a systematic review and individual patient meta-analysis.","volume":"44","author":"Harwood","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"1","key":"poi230041r3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41591-021-01627-9","article-title":"Risk factors for PICU admission and death among children and young people hospitalized with COVID-19 and PIMS-TS in England during the first pandemic year.","volume":"28","author":"Ward","year":"2022","journal-title":"Nat Med"},{"issue":"11","key":"poi230041r5","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/S1473-3099(21)00290-5","article-title":"Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.","volume":"21","author":"Bager","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"poi230041r6","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/S1473-3099(21)00580-6","article-title":"Hospitalisation associated with SARS-CoV-2 Delta variant in Denmark.","volume":"21","author":"Bager","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"poi230041r7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S2352-4642(22)00027-X","article-title":"Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 Omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study.","volume":"6","author":"Cloete","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"issue":"1","key":"poi230041r8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41390-022-02052-5","article-title":"Comparison of UK paediatric SARS-CoV-2 admissions across the first and second pandemic waves.","volume":"93","author":"Swann","year":"2023","journal-title":"Pediatr Res"},{"issue":"10332","key":"poi230041r9","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","article-title":"Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants in England: a cohort study.","volume":"399","author":"Nyberg","year":"2022","journal-title":"Lancet"},{"issue":"5","key":"poi230041r10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41577-022-00720-5","article-title":"Estimating disease severity of Omicron and Delta SARS-CoV-2 infections.","volume":"22","author":"Sigal","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"poi230041r11","doi-asserted-by":"publisher","first-page":"7251","DOI":"10.1038\/s41467-021-27202-x","article-title":"Increased transmissibility of SARS-CoV-2 lineage B.1.1.7 by age and viral load.","volume":"12","author":"Lyngse","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"poi230041r12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jinf.2022.04.020","article-title":"Very low rates of severe COVID-19 in children hospitalised with confirmed SARS-CoV-2 infection in London, England.","volume":"85","author":"Zsigmond","year":"2022","journal-title":"J Infect"},{"issue":"5","key":"poi230041r13","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1016\/S2352-4642(22)00096-7","article-title":"Risk of hospitalisation and death in children with SARS-CoV-2 Delta (B.1.612.2) infection.","volume":"6","author":"Thelwall","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"issue":"3","key":"poi230041r14","doi-asserted-by":"publisher","first-page":"e518","DOI":"10.1093\/cid\/ciac553","article-title":"Lower risk of multisystem inflammatory syndrome in children (MIS-C) with the Delta and Omicron variants of SARS-CoV-2.","volume":"76","author":"Cohen","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"8","key":"poi230041r15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/jamapediatrics.2022.0945","article-title":"Incidence rates and clinical outcomes of SARS-CoV-2 infection with the Omicron and Delta variants in children younger than 5 years in the US.","volume":"176","author":"Wang","year":"2022","journal-title":"JAMA Pediatr"},{"issue":"1829","key":"poi230041r17","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2020.0279","article-title":"Real-time nowcasting and forecasting of COVID-19 dynamics in England: the first wave.","volume":"376","author":"Birrell","year":"2021","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"7","key":"poi230041r19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S2352-4642(22)00145-6","article-title":"Delay in death registration among adolescents and young adults in England and Wales.","volume":"6","author":"Ward","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"issue":"8","key":"poi230041r20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-005331","article-title":"Estimating the prevalence of chronic conditions in children who die in England, Scotland and Wales: a data linkage cohort study.","volume":"4","author":"Hardelid","year":"2014","journal-title":"BMJ Open"},{"issue":"4","key":"poi230041r21","doi-asserted-by":"publisher","first-page":"e923","DOI":"10.1542\/peds.2011-2846","article-title":"Rising national prevalence of life-limiting conditions in children in England.","volume":"129","author":"Fraser","year":"2012","journal-title":"Pediatrics"},{"issue":"1","key":"poi230041r22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41591-021-01578-1","article-title":"Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year.","volume":"28","author":"Smith","year":"2022","journal-title":"Nat Med"},{"issue":"7","key":"poi230041r23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.15585\/mmwr.mm7107e4","article-title":"Hospitalizations of children and adolescents with laboratory-confirmed COVID-19\u2014COVID-NET, 14 States, July 2021\u2013January 2022.","volume":"71","author":"Marks","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"poi230041r24","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1056\/NEJMc2209371","article-title":"Effects of vaccination and previous infection on Omicron infections in children.","volume":"387","author":"Lin","year":"2022","journal-title":"N Engl J Med"},{"issue":"4","key":"poi230041r25","doi-asserted-by":"publisher","first-page":"P435","DOI":"10.1101\/2022.08.19.22278987","article-title":"Protection against symptomatic disease with the Delta and Omicron BA. 1\/BA. 2 variants of SARS-CoV-2 after infection and vaccination in adolescents: national observational test-negative case control study, August 2021 to March 2022, England.","volume":"23","author":"Powell","year":"2023","journal-title":"Lancet"},{"issue":"3","key":"poi230041r26","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s15010-022-01908-6","article-title":"SARS-CoV-2 variants and the risk of pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 among children in Germany.","volume":"51","author":"Sorg","year":"2023","journal-title":"Infection"},{"key":"poi230041r27","article-title":"All hospital emergency patients to be tested for coronavirus.","author":"Thomas","year":"2020","journal-title":"Health Serv J"},{"issue":"2","key":"poi230041r28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S2352-4642(20)30342-4","article-title":"Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective national cohort study using active surveillance.","volume":"5","author":"Gale","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"poi230041r4","doi-asserted-by":"crossref","unstructured":"Bertran? M, Amin-Chowdhury? Z, Davies? H, . COVID-19 deaths in children and young people: active prospective national surveillance, March 2020 to December 2021, England.? SSRN. Posted online June 20, 2022. https:\/\/papers.ssrn.com\/sol3\/papers.cfm?abstract_id=4125501","DOI":"10.2139\/ssrn.4125501"},{"key":"poi230041r16","unstructured":"NHS Digital. Control of patient information (COPI) notice. Accessed July 1, 2022. https:\/\/digital.nhs.uk\/coronavirus\/coronavirus-covid-19-response-information-governance-hub\/control-of-patient-information-copi-notice"},{"key":"poi230041r18","unstructured":"Birrell? P, Blake? J, van Leeuwen? E; MRC Biostatistics Unit COVID-19 working group; van De Angelis? D. COVID-19: nowcast and forecast. Updated December 13, 2022. Accessed September 1, 2022. https:\/\/joshuablake.github.io\/public-RTM-reports\/iframe.html"}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/articlepdf\/2807910\/jamapediatrics_ward_2023_oi_230041_1695233656.07713.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T15:00:40Z","timestamp":1695654040000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/fullarticle\/2807910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2023.2357","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,1]]}}}